{"altmetric_id":2358867,"counts":{"readers":{"mendeley":17,"citeulike":0,"connotea":0},"facebook":{"unique_users_count":1,"unique_users":["108857042530267"],"posts_count":1},"news":{"unique_users_count":1,"unique_users":["rt"],"posts_count":1},"total":{"posts_count":2}},"citation":{"abstract":"R-Ras2 is a transforming GTPase that shares downstream effectors with Ras subfamily proteins. However, little information exists about the function of this protein in tumorigenesis and its signalling overlap with classical Ras GTPases. Here we show, by combining loss- and gain-of-function studies in breast cancer cells, mammary epithelial cells and mouse models, that endogenous R-Ras2 has a role in both primary breast tumorigenesis and the late metastatic steps of cancer cells in the lung parenchyma. R-Ras2 drives tumorigenesis in a phosphatidylinostiol-3 kinase (PI3K)-dependent and signalling autonomous manner. By contrast, its prometastatic role requires other priming oncogenic signals and the engagement of several downstream elements. R-Ras2 function is required even in cancer cells exhibiting constitutive activation of classical Ras proteins, indicating that these GTPases are not functionally redundant. Our results also suggest that application of long-term R-Ras2 therapies will result in the development of compensatory mechanisms in breast tumours.","abstract_source":"pubmed","altmetric_jid":"4f6fa62f3cf058f610008259","authors":["Romain M. Larive","Giulia Moriggi","Mauricio Menacho-M\u00e1rquez","Marta Ca\u00f1amero","Enrique de \u00c1lava","Balbino Alarc\u00f3n","Mercedes Dosil","Xos\u00e9 R. Bustelo"],"doi":"10.1038\/ncomms4881","first_seen_on":"2014-05-17T20:03:13+00:00","issns":["2041-1733"],"journal":"Nature Communications","last_mentioned_on":1400152839,"links":["http:\/\/www.nature.com\/ncomms\/2014\/140514\/ncomms4881\/full\/ncomms4881.html"],"pmid":"24826867","pubdate":"2014-05-14T00:00:00+00:00","publisher":"Nature Publishing Group","publisher_subjects":[{"name":"Multidisciplinary","scheme":"era"}],"title":"Contribution of the R-Ras2 GTP-binding protein to primary breast tumorigenesis and late-stage metastatic disease","type":"article","mendeley_url":"http:\/\/www.mendeley.com\/research\/contribution-rras2-gtpbinding-protein-primary-breast-tumorigenesis-latestage-metastatic-disease"},"altmetric_score":{"score":8.25,"score_history":{"1y":0,"6m":0,"3m":0,"1m":0,"1w":0,"6d":0,"5d":0,"4d":0,"3d":0,"2d":0,"1d":0,"at":8.25},"context_for_score":{"all":{"total_number_of_other_articles":3750262,"mean":4.984926278597,"rank":395420,"this_scored_higher_than_pct":89,"this_scored_higher_than":3352568,"rank_type":"exact","sample_size":3750262,"percentile":89},"similar_age_3m":{"total_number_of_other_articles":94503,"mean":7.2559515132275,"rank":12349,"this_scored_higher_than_pct":86,"this_scored_higher_than":82068,"rank_type":"exact","sample_size":94503,"percentile":86},"this_journal":{"total_number_of_other_articles":5431,"mean":25.823933333333,"rank":2491,"this_scored_higher_than_pct":54,"this_scored_higher_than":2935,"rank_type":"exact","sample_size":5431,"percentile":54},"similar_age_this_journal_3m":{"total_number_of_other_articles":512,"mean":35.823416829746,"rank":300,"this_scored_higher_than_pct":41,"this_scored_higher_than":211,"rank_type":"exact","sample_size":512,"percentile":41}}},"demographics":{"users":{"mendeley":{"by_status":{"Researcher":4,"Student  > Ph. D. Student":3,"Student  > Postgraduate":1,"Student  > Master":4,"Other":2,"Student  > Bachelor":2,"Professor":2},"by_discipline":{"Medicine and Dentistry":3,"Neuroscience":1,"Chemistry":1,"Psychology":1,"Agricultural and Biological Sciences":12}}},"geo":{"mendeley":{"BR":1}}},"posts":{"facebook":[{"url":"https:\/\/www.facebook.com\/permalink.php?story_fbid=644461662303133&id=108857042530267","license":"public","citation_ids":[2358867],"posted_on":"2014-05-15T11:20:39+00:00","summary":"Descubren una proteina que si se elimina bloquea el desarrollo del cancer de mama incluidas las celulas metast\u00e1sicas en el Centro del Cancer de Salamanca !!! \nhttp:\/\/www.nature.com\/ncomms\/2014\/140514\/ncomms4881\/full\/ncomms4881.html","author":{"name":"Sergio Miguel Tom\u00e9","url":"https:\/\/www.facebook.com\/108857042530267","facebook_wall_name":"Sergio Miguel Tom\u00e9","image":"https:\/\/graph.facebook.com\/108857042530267\/picture","id_on_source":"108857042530267"}}],"news":[{"title":"Descubren prote\u00edna capaz de frenar el c\u00e1ncer de mama y la met\u00e1stasis de pulm\u00f3n","url":"http:\/\/actualidad.rt.com\/ciencias\/view\/128132-proteina-diana-cancer-mama?utm_source=rss&utm_medium=rss&utm_campaign=ciencias","license":"public","citation_ids":[2358867],"posted_on":"2014-05-15T08:49:57+00:00","summary":"La eliminaci\u00f3n o inhibici\u00f3n de la TC21, la prote\u00edna responsable del desarrollo del c\u00e1ncer de mama y de la met\u00e1stasis de pulm\u00f3n, frena ambas enfermedades malignas, seg\u00fan cient\u00edficos espa\u00f1oles. Afirman que la medida no causa da\u00f1os al organismo.","author":{"name":"RT Network","url":"http:\/\/actualidad.rt.com\/","image":"https:\/\/s3.amazonaws.com\/weyland.altmetric.com\/news_sources\/logos\/000\/000\/300\/normal\/Screen_Shot_2016-02-02_at_12.02.20.png?1454414557"}}]}}